Novel Approaches to Managing Patients with Relapsed and Refractory Waldenström Macroglobulinemia [0.03%]
治疗复发及难治性瓦尔登斯特伦巨球蛋白血症患者的新型策略
Karan L Chohan,Prashant Kapoor
Karan L Chohan
Purpose of review: Waldenström macroglobulinemia is a rare non-Hodgkin lymphoma (NHL) characterized by lymphoplasmacytic bone marrow infiltration associated with an immunoglobulin M (IgM) monoclonal gammopathy. Over the ...
MRD in Philadelphia Chromosome-Positive ALL: Methodologies and Clinical Implications [0.03%]
费城染色体阳性急性淋巴细胞白血病的微小残留病：方法学与临床意义
Valerie Tran,Kiarash Salafian,Kenan Michaels et al.
Valerie Tran et al.
Purpose of review: Measurable residual disease (MRD) is integral in the management of Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL). This review discusses the current methods used to evaluate M...
Glucocorticoid Therapy in Acute Lymphoblastic Leukemia: Navigating Short-Term and Long-Term Effects and Optimal Regimen Selection [0.03%]
急性淋巴细胞白血病的糖皮质激素治疗：短程与长程疗效及优化方案选择导航
Hoda Pourhassan,Lindsey Murphy,Ibrahim Aldoss
Hoda Pourhassan
Purpose of review: Glucocorticoids are a mainstay in acute lymphoblastic leukemia treatment and lack of early response is predictive for overall disease prognosis. Given the vital position of glucocorticoids and well know...
Use of Patient-Centered Technology and Digital Interventions in Pediatric and Adult Patients with Hematologic Malignancies [0.03%]
用于血液系统恶性肿瘤儿科和成人患者的以患者为中心的技术和数字干预措施的使用
Rachel S Werk,Mallorie B Heneghan,Sherif M Badawy
Rachel S Werk
Purpose of review: As society continues to advance in technology, it is important to address how this advancement can impact and enhance patient care. The purpose of this review is to identify patient-centered technology ...
Correction to: Treatment of Myelodysplastic Syndromes for Older Patients: Current State of Science, Challenges, and Opportunities [0.03%]
髓系肿瘤老年患者的一线治疗：科学现状、挑战和机遇（被更正）
Tariq Kewan,Maximillian Stahl,Jan Philipp Bewersdorf et al.
Tariq Kewan et al.
Published Erratum
Current hematologic malignancy reports. 2024 Jun;19(3):151. DOI:10.1007/s11899-024-00734-x 2024
Treatment of Myelodysplastic Syndromes for Older Patients: Current State of Science, Challenges, and Opportunities [0.03%]
老年髓系肿瘤患者的治疗：科学现状、挑战与机遇
Tariq Kewan,Maximillian Stahl,Jan Philipp Bewersdorf et al.
Tariq Kewan et al.
Purpose of review: Myelodysplastic syndromes/neoplasms (MDS) represent a diverse group of pathologically distinct diseases with varying prognoses and risks of leukemia progression. This review aims to discuss current trea...
Bruton Tyrosine Kinase Inhibition: an Effective Strategy to Manage Waldenström Macroglobulinemia [0.03%]
布鲁顿酪氨酸激酶抑制在治疗华氏巨球蛋白血症中的有效策略
Reema K Tawfiq,Jithma P Abeykoon,Prashant Kapoor
Reema K Tawfiq
Purpose of review: The treatment of Waldenström macroglobulinemia (WM) has evolved over the past decade. With the seminal discoveries of MYD88 and CXCR warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) m...
Jane J Chen,Franco Castillo Tokumori,Christina Del Guzzo et al.
Jane J Chen et al.
Purpose of review: T-cell lymphomas (TCLs) are a group of rare subtypes of non-Hodgkin lymphoma derived from mature T-lymphocytes. Recent updates in lymphoma classification based on the cell-of-origin pathogenesis have sh...
Management of Patients with Early Myelofibrosis: A Discussion of Best Practices [0.03%]
早期骨纤维化的患者管理：最佳实践的讨论
Prithviraj Bose
Prithviraj Bose
Purpose of review: Summarize best practices for management of patients with early myelofibrosis (MF). Recent findings: Myelofibrosis is...
Tyrosine Kinase Inhibitor Discontinuation in Chronic Myeloid Leukemia: Strategies to Optimize Success and New Directions [0.03%]
慢性髓性白血病中酪氨酸激酶抑制剂的停用：优化成功的策略及新方向
Delphine Rea,Sofiane Fodil,Etienne Lengline et al.
Delphine Rea et al.
Purpose of review: The discovery that patients suffering from chronic myeloid leukemia who obtain deep and long-lasting molecular responses upon treatment with tyrosine kinase inhibitors may maintain their disease silent ...